Cyclooxygenase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Fertility and Sterility

• Publication date

  2004-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.FERTNSTERT.2004.07.946PMID 15589867
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclooxygenase-2 expression in deep endometriosis and matched eutopic endometrium.

  2004cited by this paper
• Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.

  2003cited by this paper
• Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?

  2003cited by this paper
• Antiangiogenic agents are effective inhibitors of endometriosis.

  2003cited by this paper
• Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue.

  2002cited by this paper
• Using Rats as a Research Model for the Study of Endometriosis

  2002cited by this paper
• Pathological evaluation of the rat endometriosis model.

  2002cited by this paper
• Increased Expression of Cyclooxygenase‐2 in Local Lesions of Endometriosis Patients

  2002cited by this paper
• Survivin gene expression in endometriosis.

  2002cited by this paper
• Progesterone‐Mediated Endometrial Maturation Limits Matrix Metalloproteinase (MMP) Expression in an Inflammatory‐like Environment

  2002cited by this paper
• Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer.

  2002cited by this paper
• Expression of the cyclin-dependent kinase inhibitor p27Kip1 in eutopic endometrium and peritoneal endometriosis.

  2001cited by this paper
• COX‐2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX‐2 inhibitor celecoxib

  2001cited by this paper
• [Management of recurrent endometriosis].

  2001cited by this paper
• Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis.

  2001cited by this paper
• Host cyclooxygenase-2 modulates carcinoma growth.

  2000cited by this paper
• Vascular endothelial growth factor and endometriotic angiogenesis.

  2000cited by this paper
• Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis.

  1999cited by this paper
• Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target.

  1999cited by this paper
• Angiogenesis: a new theory for endometriosis.

  1998cited by this paper
• Vascular endothelial growth factor (VEGF) in endometriosis.

  1998cited by this paper
• Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice.

  1997cited by this paper
• Effects of the progesterone antagonists onapristone (ZK 98 299) and ZK 136 799 on surgically induced endometriosis in intact rats.

  1996cited by this paper
• Effects of the progesterone antagonists onapristone (ZK 98 299) and ZK 136 799 on surgically induced endometriosis in intact rats

  1995cited by this paper
• Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells (*)

  1995cited by this paper
• The effect of a luteinizing hormone-releasing hormone antagonist on experimental endometriosis in the rat.

  1987cited by this paper
• Etiology, prevention, and inhibition of endometriosis.

  1980cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Prostaglandin E 2 Stimulates Aromatase Expression in

  year unknowncited by this paper

• Cyclooxygenase 2 overexpression suppresses Smad3 and augments ERK1/2 signaling activated by TGFβ1 in endometrial stromal cells: a novel insight into endometriosis pathogenesis.

  2025cites this paper
• Endometriosis and aspirin: a systematic review

  2024cites this paper
• Experimental Animal Models in Obstetrics and Gynecology

  2024cites this paper
• Effects of selective inhibition of prostaglandin E2 receptors EP2 and EP4 on the miRNA profile in endometriosis.

  2022cites this paper
• Endometriosis: current challenges in modeling a multifactorial disease of unknown etiology

  2020cites this paper
• Dose-dependent pro- or anti-fibrotic responses of endometriotic stromal cells to interleukin-1β and tumor necrosis factor α

  2020cites this paper
• Lipoxin A4 Suppresses IL-1β-Induced Cyclooxygenase-2 Expression Through Inhibition of p38 MAPK Activation in Endometriosis

  2019cites this paper
• Suppressive Effects of Ursolic Acid on Human Endometriotic Stromal Cells Survival

  2019cites this paper
• The expression of prostaglandin E receptors and their roles in healthy and diseased endometrium

  2019cites this paper
• Exposure to environmental concentrations of hexachlorobenzene induces alterations associated with endometriosis progression in a rat model.

  2019cites this paper
• Design and Synthesis of new Naproxen Analogues as Potential Anti-inflammatory Agents

  2018cites this paper
• Investigational drugs for the treatment of endometriosis, an update on recent developments

  2018cites this paper
• Synthesis and Preliminary Pharmacological Evaluation of New Analogues of Diclofenac as Potential Anti-inflammatory Agents

  2017cites this paper
• Surgery for Benign Gynecological Disorders Improve Endometrium Receptivity

  2017cites this paper
• Macrophages promote the growth and invasion of endometrial stromal cells by downregulating IL-24 in endometriosis.

  2016cites this paper
• Enhanced cyclooxygenase-2 expression levels and metalloproteinase 2 and 9 activation by Hexachlorobenzene in human endometrial stromal cells.

  2016cites this paper
• An overview of early drug development for endometriosis

  2016cites this paper
• Evaluation of peritoneal endometriosis treatment using intralesional acetylsalicylic acid injection in rabbits.

  2016cites this paper
• An Update on Pathophysiology and Medical Management of Endometriosis

  2016cites this paper
• Selective inhibition of prostaglandin E2 receptors EP2 and EP4 modulates DNA methylation and histone modification machinery proteins in human endometriotic cells.

  2015influential citation
• COX-2 gene promoter DNA methylation status in eutopic and ectopic endometrium of Egyptian women with endometriosis.

  2015cites this paper
• Thalidomide affects experimental endometriosis: A randomized controlled study in the rat

  2014cites this paper
• Prostaglandin E and F receptors in the uterus

  2014cites this paper
• Endometriosis: translation of molecular insights to management.

  2014cites this paper
• Prevention of Endometriosis

  2014cites this paper
• Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Inhibits Adhesion of Human Endometriotic Epithelial and Stromal Cells Through Suppression of Integrin-Mediated Mechanisms1

  2013cites this paper
• Regression of Experimentally Induced Endometriosis with a New Selective Cyclooxygenase-2 Enzyme Inhibitor

  2013cites this paper
• Anti-angiogenic treatment strategies for the therapy of endometriosis.

  2012cites this paper
• Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Inhibits Adhesion of Human Endometriotic Epithelial and Stromal Cells Through Suppression of Integrin-Mediated Mechanisms Short Title: PGE2 signaling in adhesion of human endometriotic cells

  2012cites this paper
• Regulación del crecimiento del tejido endometrial en respuesta a nuevas alternativas terapéuticas propuestas para tratar la endometriosis

  2012cites this paper
• Angiogenesis and microvasculature in the female reproductive organs: physiological and pathological implications.

  2012cites this paper
• The role of NF-kappaB in endometriosis.

  2012cites this paper
• DNA hypomethylation of the COX-2 gene promoter is associated with up-regulation of its mRNA expression in eutopic endometrium of endometriosis

  2012cites this paper
• Pharmacologic therapies in endometriosis: a systematic review.

  2012cites this paper
• Peritoneal endometriosis is an inflammatory disease.

  2012cites this paper
• Omega 3 Fatty Acids Counteract IL-8 and Prostaglandin E2 Secretion Induced by TNF-α in Cultured Endometrial Stromal Cells

  2011cites this paper
• The translational challenge in the development of new and effective therapies for endometriosis: a review of confidence from published preclinical efficacy studies.

  2011influential citation
• The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis.

  2011cites this paper
• Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study.

  2011cites this paper
• Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases.

  2011cites this paper
• The inducible prostaglandin E synthase mPGES-1 regulates growth of endometrial tissues and angiogenesis in a mouse implantation model.

  2011cites this paper
• Hypoxia induces expression of COX-2 through the homeodomain transcription factor CDX1 and orphan nuclear receptor SHP in human endometrial cells.

  2011cites this paper
• [Relevance of apoptosis in the female reproductive system].

  2011cites this paper
• Relevancia de la apoptosis en la reproducción femenina.

  2011cites this paper
• Endometriotic Implants Regress in Rat Models Treated With Puerarin by Decreasing Estradiol Level

  2011cites this paper
• A Long-Acting Tumor Necrosis Factor α-Binding Protein Demonstrates Activity in Both In Vitro and In Vivo Models of Endometriosis

  2010cites this paper
• Expression and possible role of non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) in the human endometrium and endometriosis.

  2010cites this paper
• Expression of eicosanoid biosynthetic and catabolic enzymes in peritoneal endometriosis.

  2010cites this paper
• The role of microRNAs in endometriosis and associated reproductive conditions.

  2010cites this paper
• A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model.

  2010cites this paper
• A Long Acting TNF α Binding Protein Demonstrates Activity in both in vitro and in vivo Models of Endometriosis

  2010influential citation
• Expression of COX-2 in intestinal endometriosis to: Tokyol C, et al. Int J Gynecol Pathol 2009;28:148-56.

  2010cites this paper
• Selective blockade of prostaglandin E2 receptors EP2 and EP4 signaling inhibits proliferation of human endometriotic epithelial cells and stromal cells through distinct cell cycle arrest.

  2010cites this paper
• Induction of peritoneal endometriosis in nude mice with use of human immortalized endometriosis epithelial and stromal cells: a potential experimental tool to study molecular pathogenesis of endometriosis in humans.

  2009cites this paper
• Involvement of Iron, Nuclear Factor-Kappa B (NF-κB) and Prostaglandins in the Pathogenesis of Peritoneal Endometriosis-Associated Inflammation: A Review

  2009cites this paper
• Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms.

  2009cites this paper
• Involvement of iron, nuclear factor-kappa B (NF-KB) and prostaglandins in the pathogenesis of peritoneal endometriosis-associated inflammation: A review

  2009cites this paper
• A Botanical Extract from Channel Flow Inhibits Cell Proliferation, Induces Apoptosis, and Suppresses CCL5 in Human Endometriotic Stromal Cells1

  2009cites this paper
• Cyclooxygenase-2 overexpression in ovarian endometriomas is associated with higher risk of recurrence.

  2009cites this paper
• Cyclooxygenase-2 expression, Ki-67 labeling index, and perifocal neovascularization in endometriotic lesions.

  2009cites this paper
• Non-steroidal targets in the diagnosis and treatment of endometriosis.

  2008cites this paper
• New drugs in development for the treatment of endometriosis.

  2008cites this paper
• Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis.

  2008cites this paper
• Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises.

  2008cites this paper
• Interleukin (IL)-17A stimulates IL-8 secretion, cyclooxygensase-2 expression, and cell proliferation of endometriotic stromal cells.

  2008cites this paper
• Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis.

  2008influential citation
• Gene expression profiles and functional characterization of human immortalized endometriotic epithelial and stromal cells.

  2008cites this paper
• Angiogenese in der Pathophysiologie und Therapie der Endometriose : Eine experimentelle in vivo Studie am Syrischen Goldhamster

  2008cites this paper
• New drugs in development for the treatment of endometriosis

  2008cites this paper
• Emerging drugs for endometriosis

  2008cites this paper
• Cyclooxygenase-2 regulates survival, migration, and invasion of human endometriotic cells through multiple mechanisms.

  2008cites this paper
• Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis.

  2007cites this paper
• In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis.

  2007cites this paper
• Endometriose und Inflammation

  2007cites this paper
• Suppression of IL-1β-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells

  2007cites this paper
• Angiogenesis and antiangiogenic therapy in endometriosis.

  2007cites this paper
• Suppression of IL-1beta-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells.

  2007cites this paper
• Evolution of medical treatment for endometriosis: back to the roots?

  2007cites this paper
• Nuclear factor-kappab (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large?

  2007cites this paper
• Expression of Inducible Microsomal Prostaglandin E Synthase in Local Lesions of Endometriosis Patients

  2007cites this paper
• Molecular profiling of experimental endometriosis identified gene expression patterns in common with human disease.

  2007cites this paper
• Nuclear Factor-κB (NF-κB): An Unsuspected Major Culprit in the Pathogenesis of Endometriosis That Is Still at Large?

  2006cites this paper
• Inhibition of Proliferation of Endometrial Stromal Cells by Trichostatin A, RU486, CDB-2914, N-Acetylcysteine, and ICI 182780

  2006cites this paper
• Animal models in endometriosis research.

  2006cites this paper
• Emerging drugs in endometriosis

  2006cites this paper
• A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice.

  2006cites this paper
• Endometriosis: harmful survival of an ectopic tissue.

  2006cites this paper
• Increased cyclooxygenase-2 expression is associated with better clinical outcome in patients submitted to complete ablation for severe endometriosis.

  2005cites this paper
• Matrix-Metalloproteinasen (MMPs) und deren Bedeutung für die Menstruation und Endometriose

  2005cites this paper
• Reply: Is the dose to inhibit the COX-2 enzyme in nude mice also adequate in human endometrial tissues?

  2005cites this paper
• Sulindac suppresses nuclear factor-kappaB activation and RANTES gene and protein expression in endometrial stromal cells from women with endometriosis.

  2005cites this paper
• Future Perspectives in the Medical Treatment of Endometriosis

  2005cites this paper
• Is the dose to inhibit the COX-2 enzyme in nude mice also adequate in 'human' endometrial tissues?

  2005cites this paper